Author Correction: LncRNA HOTAIRM1 inhibits the progression of hepatocellular carcinoma by inhibiting the Wnt signaling pathway
Y. Zhang, L. Mi, Y. Xuan, C. Gao, Y.-H. Wang, H.-X. Ming, J. Liu Department of Hepatobiliary Surgery, Provincial Hospital Affiliated to Shandong University, Jinan, China
Correction to: European Review for Medical and Pharmacological Sciences 2018; 22 (15): 4861-4868–DOI: 10.26355/eurrev_201808_15622–PMID: 30070317, published online 15 August 2018.
After publication, the authors found some mistakes in the article.
There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause.
https://www.staging.europeanreview.org/article/15622
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
Y. Zhang, L. Mi, Y. Xuan, C. Gao, Y.-H. Wang, H.-X. Ming, J. Liu
Author Correction: LncRNA HOTAIRM1 inhibits the progression of hepatocellular carcinoma by inhibiting the Wnt signaling pathway
Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 18
Pages: 5578-5578
DOI: 10.26355/eurrev_202109_26774